In the cohort of patients with resectable lung adenocarcinoma (Additional file 4: Table S3), E-cadherin loss was predictive of worse survival and more aggressive behavior (Additional file 5: Figure S1C and D). Here, CDH1 is linked to lung adenocarcinoma.